-
Apr 18, 2021 06:26 PM IST The CRAMs ( contract research and manufacturing services) segment is fetching rich valuations globally and back home, the segment has seen minority stake sale deals like True North-Anthem Biosciences & TPG-Sai Lifesciences.
-
Apr 14, 2021 10:51 AM IST Most brokerages anticipate sequential moderation in revenue, EBITDA and PAT for pharma firms for Q4FY21. However, the numbers may still be better on a year-on-year (YoY) basis.
- Apr 12, 2021 09:50 PM IST
With the second Covid ‘Wave’ already surpassing the daily highs recorded in the month of September 2020 of about 95000, the demand for vaccines, critical medical equipment like vaccines, oxygen cylinders and ventilators have increased manifold. Watch the video to know what this evolving situation means for Indian Pharma?
- Feb 26, 2021 09:59 AM IST
The government's decision to expand the production-linked incentive to the pharma sector will help players who have a strong manufacturing base, say experts.
- Feb 24, 2021 03:44 PM IST
Centre believes PLI scheme will make India's $ 40 billion pharmaceuticals industry globally competitive and less reliant on imports for high-end patented drugs. The new incentives for domestic manufacture of IT hardware aims to raise domestic value addition to 20% - 25% by 2025 and make India a global hub for Electronics System Design and Manufacturing.
- Feb 11, 2021 01:30 PM IST
Merck is now considering a range of options, both in the United States and around the world, mindful that anything it chooses to do would take months to bring to fruition, given the complexity of the manufacturing process
- Feb 05, 2021 09:23 AM IST
Vaccine scope, strong product pipeline to act as tonic for Dr Reddy's Laboratories
- Feb 05, 2021 09:21 AM IST
The sector was in focus in Union Budget 2021. Finance Minister Nirmala Sitharaman in her Budget speech announced an outlay of Rs 2,23,846 crore for health and well being.
- Feb 04, 2021 11:45 AM IST
Laurus lab's earnings growth is likely to maintain a strong momentum even beyond the forecast period on new capacity addition and foray into high growth areas of biotech, CDMO and oncology APIs
- Feb 03, 2021 09:57 AM IST
New launches in the US, particularly in the inhalation category, and an improving market share are expected to help ride over structural pricing erosion in the near term for Lupin
- Feb 01, 2021 07:32 PM IST
Focus on creating health infrastructure in the Budget 2021 is clearly an incrementally structural move which should indirectly benefit all the domestic oriented companies
- Jan 31, 2021 10:16 PM IST
Large part of impairment charge taken by Dr Reddy's is explained by the erosion in the value of Nuvaring due to the launch of the additional generic product by Teva
- Jan 31, 2021 12:48 PM IST
In the US market, Albuterol opportunity remains a key lever for Cipla at least till the time Perrigo re-enters although in terms of market share, the drugmaker may be close to maturity
- Jan 31, 2021 12:42 PM IST
Sun Pharma's India business is expected to gain traction as sub-chronic and acute therapies pick up with the opening up of clinics/OPDs. This is likely to be fully backed by the field force where the expansion has recently been completed
- Jan 30, 2021 09:46 PM IST
BGI said it uses Tianhe-2 on a commercial basis, as well as other supercomputing platforms, to speed up research.
- Jan 18, 2021 11:15 PM IST
Net Sales are expected to increase by 10.4 percent Y-o-Y (up 7.6 percent Q-o-Q) to Rs. 2,315.2 crore, according to Prabhudas Lilladher.
- Jan 18, 2021 11:11 PM IST
Net Sales are expected to increase by 5.5 percent Y-o-Y (down 4.3 percent Q-o-Q) to Rs. 2,638.6 crore, according to Prabhudas Lilladher.
- Jan 18, 2021 11:11 PM IST
Net Sales are expected to increase by 17.7 percent Y-o-Y (up 3.4 percent Q-o-Q) to Rs. 283.4 crore, according to Prabhudas Lilladher.
- Jan 18, 2021 11:05 PM IST
Net Sales are expected to increase by 16.1 percent Y-o-Y (down 11.8 percent Q-o-Q) to Rs. 327.9 crore, according to Prabhudas Lilladher.
- Jan 18, 2021 11:05 PM IST
Net Sales are expected to increase by 12.3 percent Y-o-Y (up 0.5 percent Q-o-Q) to Rs. 4,397.1 crore, according to Prabhudas Lilladher.
- Jan 18, 2021 10:57 PM IST
Net Sales are expected to increase by 15.3 percent Y-o-Y (down 1.8 percent Q-o-Q) to Rs. 4,234.6 crore, according to Prabhudas Lilladher.
- Jan 18, 2021 10:52 PM IST
Net Sales are expected to increase by 5.3 percent Y-o-Y (up 0.3 percent Q-o-Q) to Rs. 3,638.1 crore, according to Prabhudas Lilladher.
- Jan 18, 2021 10:47 PM IST
Net Sales are expected to increase by 15.5 percent Y-o-Y (up 5 percent Q-o-Q) to Rs. 5,799.4 crore, according to Prabhudas Lilladher.
- Jan 14, 2021 09:49 AM IST
According to the National Health Policy, total public health expenditure is expected to hit 2.5% of GDP by 2025 from the current about 1.3%
- Jan 13, 2021 02:54 PM IST
Anticipating that the government will ask the private sector to step in and help with the nationwide vaccination drive, these startups are busy ramping up their infrastructure and training resources to be ready for the inoculation effort
